Literature DB >> 16740226

Is oocyte morphology prognostic of embryo developmental potential after ICSI?

Thomas Ebner1, Marianne Moser, Gernot Tews.   

Abstract

Metaphase II-stage oocytes collected from patients following ovarian stimulation show varying qualities. Both nuclear and cytoplasmic maturation have to be completed in a co-ordinated mode to ensure optimal conditions for subsequent fertilization. Disturbances or asynchrony of these processes may result in different morphological abnormalities, depending on whether nuclear or cytoplasmic maturation has been affected. In this respect it has been suggested that dysmorphic features occurring early in meiotic maturation may be associated with a higher frequency of aneuploidy and fertilization failure, while those occurring late in maturation may cause a higher incidence of developmental failure. In fact, more than half of the gametes collected show morphological abnormalities, some of which seem to be correlated with an impaired outcome (e.g. aggregation of endoplasmic reticulum, vacuolization, increased ooplasmic viscosity, giant eggs). Therefore, it is strongly recommended to include oocyte quality in all scoring systems applied in IVF laboratories.

Entities:  

Mesh:

Year:  2006        PMID: 16740226     DOI: 10.1016/s1472-6483(10)62006-8

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  23 in total

1.  Oocyte morphology does not affect post-warming survival rate in an egg-cryobanking donation program.

Authors:  Amanda Souza Setti; Rita de Cássia Savio Figueira; Daniela Paes de Almeida Ferreira Braga; Renata Cristina Ferreira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2011-12-04       Impact factor: 3.412

2.  The role of perivitelline space abnormalities of oocytes in the developmental potential of embryos.

Authors:  Hikmet Hassa; Yunus Aydın; Fulya Taplamacıoğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

3.  Ultrastructural and cytogenetic analyses of mature human oocyte dysmorphisms with respect to clinical outcomes.

Authors:  Mário Sousa; Mariana Cunha; Joaquina Silva; Elsa Oliveira; Maria João Pinho; Carolina Almeida; Rosália Sá; José Teixeira da Silva; Cristiano Oliveira; Alberto Barros
Journal:  J Assist Reprod Genet       Date:  2016-05-24       Impact factor: 3.412

4.  Obesity results with smaller oocyte in in vitro fertilization/intracytoplasmic sperm injection cycles-a prospective study.

Authors:  Yuval Atzmon; Ester Shoshan-Karchovsky; Medeia Michaeli; Nardin Aslih; Guy Shrem; Adrian Ellenbogen; Einat Shalom-Paz
Journal:  J Assist Reprod Genet       Date:  2017-06-17       Impact factor: 3.412

5.  The predictive value of high-magnification sperm morphology examination on ICSI outcomes in the presence of oocyte dysmorphisms.

Authors:  Amanda Souza Setti; Daniela Paes Almeida Ferreira Braga; Rita Cassia Savio Figueira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2012-10-06       Impact factor: 3.412

6.  Does morphological assessment predict oocyte developmental competence? A systematic review and proposed score.

Authors:  Alessandro Bartolacci; Giulia Intra; Giovanni Coticchio; Miriam dell'Aquila; Gilda Patria; Andrea Borini
Journal:  J Assist Reprod Genet       Date:  2022-01-07       Impact factor: 3.412

7.  Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I.

Authors:  Banchhita Sahu; Ozkan Ozturk; Nandita Deo; Karen Fordham; Massimo Ranierri; Paul Serhal
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

8.  An oocyte score for use in assisted reproduction.

Authors:  Martin Wilding; Loredana Di Matteo; Sonia D'Andretti; Nadia Montanaro; Clemente Capobianco; Brian Dale
Journal:  J Assist Reprod Genet       Date:  2007-07-15       Impact factor: 3.412

9.  GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology.

Authors:  Ana Marcia M Cota; Joao Batista A Oliveira; Claudia G Petersen; Ana L Mauri; Fabiana C Massaro; Liliane F I Silva; Andreia Nicoletti; Mario Cavagna; Ricardo L R Baruffi; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2012-04-27       Impact factor: 5.211

10.  A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF).

Authors:  Carlo Alviggi; Alberto Revelli; Paola Anserini; Antonio Ranieri; Luigi Fedele; Ida Strina; Marco Massobrio; Nicola Ragni; Giuseppe De Placido
Journal:  Reprod Biol Endocrinol       Date:  2007-12-04       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.